Follow this preprint
Efficacy and safety of Ivermectin and Hydroxychloroquine in patients with severe COVID-19. A randomized controlled trial
Jose Lenin Beltran Gonzalez, Mario González Gámez, Emanuel Antonio Mendoza Enciso, Ramiro Josue Esparza Maldonado, Daniel Hernández Palacios, Samuel Dueñas Campos, Itzel Ovalle Robles, Mariana Jocelyn Macías Guzmán, Andrea Lucia García Díaz, César Mauricio Gutiérrez Peña, Lucila Martinez Medina, Victor Antonio Monroy Colin, Arreola Guerra Jose Manuel
doi: https://doi.org/10.1101/2021.02.18.21252037
Now published in Infectious Disease Reports doi: 10.3390/idr14020020
Jose Lenin Beltran Gonzalez
1Internal Medicine Department Centenario Hospital Miguel Hidalgo
MDMario González Gámez
1Internal Medicine Department Centenario Hospital Miguel Hidalgo
MDEmanuel Antonio Mendoza Enciso
1Internal Medicine Department Centenario Hospital Miguel Hidalgo
MDRamiro Josue Esparza Maldonado
1Internal Medicine Department Centenario Hospital Miguel Hidalgo
MDDaniel Hernández Palacios
1Internal Medicine Department Centenario Hospital Miguel Hidalgo
MDSamuel Dueñas Campos
1Internal Medicine Department Centenario Hospital Miguel Hidalgo
MDItzel Ovalle Robles
1Internal Medicine Department Centenario Hospital Miguel Hidalgo
MDMariana Jocelyn Macías Guzmán
1Internal Medicine Department Centenario Hospital Miguel Hidalgo
MDAndrea Lucia García Díaz
1Internal Medicine Department Centenario Hospital Miguel Hidalgo
MDCésar Mauricio Gutiérrez Peña
1Internal Medicine Department Centenario Hospital Miguel Hidalgo
MDLucila Martinez Medina
2Pediatrics Department Centenario Hospital Miguel Hidalgo
MD, MSc.Victor Antonio Monroy Colin
2Pediatrics Department Centenario Hospital Miguel Hidalgo
MDArreola Guerra Jose Manuel
1Internal Medicine Department Centenario Hospital Miguel Hidalgo
MD MSc, PhD
Article usage
Picked up by 1 news outlets
Referenced in 1 policy documents
Tweeted by 394
On 2 Facebook pages
Posted February 23, 2021.
Efficacy and safety of Ivermectin and Hydroxychloroquine in patients with severe COVID-19. A randomized controlled trial
Jose Lenin Beltran Gonzalez, Mario González Gámez, Emanuel Antonio Mendoza Enciso, Ramiro Josue Esparza Maldonado, Daniel Hernández Palacios, Samuel Dueñas Campos, Itzel Ovalle Robles, Mariana Jocelyn Macías Guzmán, Andrea Lucia García Díaz, César Mauricio Gutiérrez Peña, Lucila Martinez Medina, Victor Antonio Monroy Colin, Arreola Guerra Jose Manuel
medRxiv 2021.02.18.21252037; doi: https://doi.org/10.1101/2021.02.18.21252037
Now published in Infectious Disease Reports doi: 10.3390/idr14020020
Subject Area
Reviews and Context
1
Comment
0
TRIP Peer Reviews
1
Community Reviews
0
Automated Services
1
Blogs/Media
0
Author Videos
Subject Areas
- Addiction Medicine (418)
- Allergy and Immunology (741)
- Anesthesia (217)
- Cardiovascular Medicine (3183)
- Dermatology (268)
- Emergency Medicine (469)
- Epidemiology (13160)
- Forensic Medicine (18)
- Gastroenterology (880)
- Genetic and Genomic Medicine (4995)
- Geriatric Medicine (460)
- Health Economics (765)
- Health Informatics (3145)
- Health Policy (1116)
- Hematology (418)
- HIV/AIDS (989)
- Medical Education (463)
- Medical Ethics (122)
- Nephrology (512)
- Neurology (4742)
- Nursing (253)
- Nutrition (702)
- Oncology (2438)
- Ophthalmology (692)
- Orthopedics (273)
- Otolaryngology (335)
- Pain Medicine (316)
- Palliative Medicine (89)
- Pathology (525)
- Pediatrics (1267)
- Primary Care Research (539)
- Public and Global Health (7307)
- Radiology and Imaging (1641)
- Respiratory Medicine (955)
- Rheumatology (468)
- Sports Medicine (411)
- Surgery (528)
- Toxicology (66)
- Transplantation (226)
- Urology (196)